Log on / register
Feedback | Support | My details
Substantially improved pharmacokinetics of recombinant human butyrylcholinesterase by fusion to human serum albumin.
Huang YJ, Lundy PM, Lazaris A, Huang Y, Baldassarre H, Wang B, Turcotte C, Côté M, Bellemare A, Bilodeau AS, Brouillard S, Touati M, Herskovits P, Bégin I, Neveu N, Brochu E, Pierson J, Hockley DK, Cerasoli DM, Lenz DE, Wilgus H, Karatzas CN, Langermann S
BMC Biotechnol 2008, 8:50
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

BioMed Central articles that cite the above article:

1.


Research article    
Addition of a sequence from 2-antiplasmin transforms human serum albumin into a blood clot component that speeds clot lysis
Sheffield WP, Eltringham-Smith LJ, Gataiance S, Bhakta V
BMC Biotechnology 2009, 9:15 (3 March 2009)
 [Abstract] [Full text] [PDF] [PubMed] [Related articles]

You can also check ISI Web of Science for additional citations (subscription required)
printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.